INTRODUCTION
============

Asthma is a common clinical condition characterized by variable airway obstruction and hyper-responsiveness sustained by chronic inflammation.^[@R1],[@R2]^ It is a worldwide problem, with an estimated 300 million affected individuals, and it is believed to contribute to one of every 250 deaths.^[@R3],[@R4]^ The annual economic cost of asthma was \$56 billion in the United States between 2002 and 2007.^[@R5]^ Days lost from work have also been reported as a substantial economic and social consequence of asthma in the United States, the United Kingdom, and Asian regions.^[@R6]--[@R8]^

Patients with asthma are noted to face higher risk of pulmonary complications during the perioperative period and increased risks of various complications after surgeries.^[@R9]--[@R11]^ Asthma increased risk of respiratory complications after adeno-tonsillectomy in children with obstructive breathing during sleep.^[@R9]^ Although the incidence of perioperative bronchospasm and laryngospasm was low, complications increased in elderly patients and in those with active asthma.^[@R10]^ These studies, however, were limited to asthma patients without adequate control, or focused on a single type of surgery or single outcome after surgery.^[@R9]--[@R11]^

The association between preoperative asthma and postoperative adverse events was not completely understood. We conducted this nationwide retrospective matched-cohort study using Taiwan\'s National Health Insurance Research Database to investigate comprehensive postoperative major complications and mortality for patients with asthma when receiving major surgeries. The impacts of various severity-related clinical characteristics of asthma on patients' postoperative adverse events were also evaluated.

METHODS
=======

Data Sources
------------

Retrospective data were collected from reimbursement claims of Taiwan\'s National Health Insurance Program, which was implemented in March 1995 and covers more than 99% of the 22.6 million Taiwan residents. The National Health Research Institutes of Taiwan established a National Health Insurance Research Database that records all beneficiaries' medical services, including inpatient and outpatient demographics, primary and secondary diagnoses, procedures, prescriptions and medical expenditures for public research interest. The validity of this database has been favorably evaluated, and research articles based on it have been accepted in prominent scientific journals worldwide.^[@R12]--[@R14]^

Ethical Approval
----------------

Insurance reimbursement claims from the National Health Insurance Research Database are available for public access. To protect personal privacy, the electronic database with patient identifications was decoded and scrambled for further research access. Although informed consent was not required because of this privacy protection, this study was approved both by the Taiwan\'s National Health Research Institutes (NHIRD-103-121) and Taipei Medical University\'s Institutional Review Board (TMU-JIRB-201505055; TMU-JIRB-201404070).^[@R12]--[@R14]^

Study Population
----------------

We examined medical claims and identified 24,109 patients ≥20 years of age with preoperative asthma from 1,834,149 surgical patients who underwent major inpatient surgeries between 2008 and 2010 in Taiwan. These surgeries required general, epidural, or spinal anesthesia and hospitalization for more than 1 day. To identify patients with asthma more strictly and to avoid those with minor or borderline asthma, the current study required at least 2 visits for medical care with primary diagnosis of asthma from physicians specialized in pulmonary medicine within the 24-month preoperative period of index surgery. Using matching procedure by propensity score with age, sex, low income, types of surgery, risk of surgery, types of anesthesia, operation in teaching hospital, and coexisting medical conditions, we selected 24,109 surgical patients from surgical patient populations who were free from diagnosis of asthma, preoperatively.

Measures and Definitions
------------------------

We identified income status by defining low-income patients as those qualifying for waived medical copayment, because this status is verified by the Taiwan Bureau of National Health Insurance. Also recorded were whether the surgery was performed in a teaching hospital and the types of surgery and anesthesia. We used the *International Classification of Diseases, Ninth Revision, Clinical Modification* (ICD-9-CM) to define preoperative medical diseases and postoperative complications. Preoperative asthma (ICD-9-CM 493) was defined as the major exposure. Coexisting medical conditions were determined from medical claims for the 24-month preoperative period, including hypertension (ICD-9-CM 401--405), mental disorders (ICD-9-CM 290--319), diabetes (ICD-9-CM 250), hyperlipidemia (ICD-9-CM 272.0, 272.1, 272.2), congestive heart failure (ICD-9-CM 428), liver cirrhosis (ICD-9-CM 571.2 and 571.5), and renal dialysis (administration code D8, D9). Thirty-day in-hospital mortality after the index surgery and postoperative complications were considered as the study\'s outcomes. These complications included pneumonia (ICD-9-CM 480--486), septicemia (ICD-9-CM 038 and 998.5), and urinary tract infection (ICD-9-CM 599.0).

This study also considered patients receiving asthma-related systemic corticosteroids, such as methylprednisolone, prednisolone, dexamethasone or hydrocortisone orally or intravenously. We also identified patients receiving emergency care, hospitalization or intensive care unit (ICU) admissions for asthma within the 24 months, preoperatively.

Statistical Analysis
--------------------

We used propensity score-matched pair method to analyze asthma patients and nonasthma controls. We developed a nonparsimonious multivariable logistic regression model to estimate a propensity score for preoperative asthma, irrespective of outcome. Clinical significance guided the initial choice of covariates in this model: age, sex, low income, hypertension, mental disorders, diabetes, hyperlipidemia, congestive heart failure, liver cirrhosis, renal dialysis, operation in teaching hospital, types of surgery, risk of surgery, and types of anesthesia. The χ^2^ tests were used to measure covariate balance and a *P*-value \<0.05 was suggested to represent meaningful covariate imbalance. We matched patients with asthma to nonasthma patients using a greedy-matching algorithm with a calliper width of 0.2 standard deviations of the log odds of the estimated propensity score. This method could remove 98% of the bias from measured covariates.^[@R12],[@R15]^

Adjusted odds ratios (ORs) with 95% confidence intervals (CIs) for 30-day postoperative pneumonia, septicemia, urinary tract infection and mortality between patients with and without asthma were analyzed with multivariate logistic regression by controlling sex, age, types of surgery and anesthesia, risk of surgery, operation in teaching hospital and preoperative coexisting medical conditions. The adjusted ORs and 95% CIs of 30-day postoperative pneumonia, septicemia, urinary tract infection, and mortality associated with preoperative asthma-related emergency care, hospitalizations, ICU admissions and use of systemic corticosteroids were calculated in the multivariate logistic regressions. SAS version 9.1 (SAS Institute Inc, Cary, NC) statistical software was used for data analyses; 2-sided *P* value \<0.05 indicated significant differences between groups.

RESULTS
=======

After being matched by propensity score procedure, there were no significant differences between surgical patients with and without asthma relating to age, sex, low income, types of surgery, risk of surgery, types of anesthesia, operation in teaching hospital, hypertension, mental disorders, diabetes, hyperlipidemia, congestive heart failure, liver cirrhosis, and renal dialysis (Table [1](#T1){ref-type="table"}).

###### 

Baseline Characteristics of Surgical Patients With Asthma and Controls^∗^
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Compared with surgical patients without asthma (Table [2](#T2){ref-type="table"}), asthmatic patients had higher risks of postoperative pneumonia (OR = 1.48; 95% CI 1.34--1.64), septicemia (OR = 1.11; 95% CI 1.02--1.21), and urinary tract infection (OR = 1.17; 95% CI 1.09--1.26). Use of emergency medical services because of asthma within the 3 preoperative months was associated with higher rates for pneumonia (OR = 2.03; 95% CI 1.57--2.63), septicemia (OR = 1.44; 95% CI 1.13--1.85), and postoperative mortality (OR = 1.84; 95% CI 1.11--3.04). Increased risks of postoperative pneumonia (OR = 2.68; 95% CI 1.86--3.85) and urinary tract infection (OR = 1.75; 95% CI 1.27--2.41) were also noted in asthmatic patients who were hospitalized for asthma in the 3 months before the index surgery. The adjusted ORs for postoperative pneumonia, septicemia, and urinary tract infection associated with preoperative inpatient care ≥11 cumulative days for asthma in the 24 months before the surgery were 1.69 (95% CI 1.29--2.21), 1.69 (95% CI 1.35--2.12), and 1.71 (95% CI 1.39--2.11), respectively. Among patients with asthma, those with preoperative admission to ICU because of asthma had significantly higher risk of postoperative pneumonia (OR = 1.64; 95% CI 1.37--1.97), septicemia (OR = 1.75; 95% CI 1.50--2.05), urinary tract infection (OR = 1.85; 95% CI 1.60--2.15), and mortality (OR = 1.88; 95% CI 1.35--2.62).

###### 

Risk of Complications Associated With Asthma in the Multiple Logistic Regression Models
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Table [3](#T3){ref-type="table"} shows that the medication of systemic corticosteroids for surgical patients with primary diagnosis of asthma within 3 months preoperatively was an independent risk factor for postoperative pneumonia (OR = 1.75; 95% CI 1.44--2.11), septicemia (OR = 1.53; 95% CI 1.29--1.82), urinary tract infection (OR = 1.39; 95% CI 1.18--1.63), and mortality (OR = 1.53; 95% CI 1.04--2.25). Asthmatic patients' emphysema (OR = 2.16; 95% CI 1.24--3.74), chronic bronchitis (OR = 1.84; 95% CI 1.58--2.14), and bronchiectasis (OR = 2.40; 95% CI 1.67--3.43) have impacts on postoperative pneumonia.

###### 

Association between Preoperative Systemic Steroid Use and Postoperative Adverse Events in Patients With Asthma
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DISCUSSION
==========

This is the first nationwide population-based cohort study using propensity score-matched procedure and multivariate adjustment to evaluate postoperative major adverse outcomes in surgical patients with various clinical scenarios of asthma. Our findings showed patients with asthma had higher risks of postoperative pneumonia, septicemia, and urinary tract infection when compared with nonasthmatic patients. Among surgical patients with asthma, preoperative emergency visits, hospitalizations, or ICU stay because of asthma significantly increased postoperative adverse events. Preoperative use of systemic corticosteroids was also identified as an independent risk factor for postoperative complications and mortality.

Cardiovascular diseases, mental disorders, diabetes, and hyperlipidemia were identified as common coexisting medical conditions for patients with asthma and contributed to increased health care use, poor quality of life, and inadequate control for asthma.^[@R16]--[@R19]^ These comorbidities may change the asthma phenotype and act as confounding factors in assessment of asthma control and outcomes.^[@R17]^ Coexisting medical conditions, including diabetes, schizophrenia and liver cirrhosis, have been associated with postoperative adverse outcomes.^[@R12]--[@R14]^ To reduce confounding bias, these potential confounding factors were properly adjusted under matching procedure with propensity score and multivariate regression models in this study.

Hospitalization for asthma and use of systemic corticosteroids during the preceding 6 months might increase risk of future hospital admissions for asthma.^[@R20]^ This study showed history of asthma exacerbation in the prior 12 months is one of the strongest predictors of future exacerbations.^[@R21]^ We also found that the history of asthma-specific emergency visits, hospitalizations, ICU stay, and use of systemic corticosteroids were independent contributing factors for postoperative major adverse outcomes in asthmatic patients. Surgical patients with emergency care for asthma in the preoperative 3 months had nearly doubled risk of postoperative mortality compared with controls. Patients who were hospitalized for asthma in the 3 months preceding surgery had almost 3 times the risk of developing postoperative pneumonia compared with controls. Cumulative asthma-specific hospital stay and ICU admissions because of asthma in the prior 24 months were significantly associated with increased risk of postoperative complications and mortality.

Use of systemic corticosteroids is highly associated with the potential infectious complications because these inhibit the immune system and reduce inflammatory response, which may predispose patients to infection.^[@R22]^ A retrospective cohort study reported that asthmatic patients treated preoperatively with systemic corticosteroids received surgical procedures with a relatively low incidence of complications, including postoperative bronchospasm and wound infection.^[@R23]^ Another investigation showed corticosteroid-dependent asthmatic patients can tolerate surgical procedures well without serious pulmonary or wound complications.^[@R24]^ These studies, however, are limited by small sample sizes and are prone to referral bias, or lack the power to identify independent predictors of morbidity and mortality in surgical patients with asthma. Our study showed that use of systemic corticosteroids within 3 months before surgery significantly increased postoperative morbidity and mortality in asthmatic patients. The use of systemic corticosteroids implied that patients might have been treated with steroids because of active asthma, exacerbation of chronic asthma, or in a state of possible immune-suppression, all of which might contribute to increased postoperative morbidity and mortality. As history of asthma exacerbation can be easily and reliably obtained in preoperative evaluation, this should be routinely checked during preoperative assessment of surgical risks for asthmatic patients, especially their use of systemic corticosteroids, emergency visits, hospitalization, or ICU admission for asthma.^[@R25]^

Although the reason asthmatic patients had more postoperative adverse events than the general population is still unclear, several explanations can be considered. First, patients with asthma have increased risks of airway-related infections.^[@R26]--[@R28]^ Impaired innate and adaptive immune functions among asthmatic patients have been suggested as potential underlying mechanisms.^[@R29],[@R30]^ Second, psychologic stress has been suspected as an asthma trigger in recent decades.^[@R31],[@R32]^ Rather than directly causing the asthma symptoms, stress modulates the immune system and increases the magnitude of airway inflammatory response to allergens and irritants.^[@R33]^ Third, a number of perioperative medications, including anesthetics, can induce allergic reactions through histamine release. Neuromuscular blocking drugs are the most common medications to cause allergic reactions in the operating theatre, and some, such as mivacurium and atracurium, have histamine-releasing effects.^[@R34]^ Intraoperative IgE-mediated anaphylaxis can be triggered by rocuronium, succinylcholine, and vecuronium.^[@R35]^ There is a concern that nonsynthetic opioids such as morphine can induce bronchospasm through histamine release; however, few subject data support this.^[@R36]^ In addition, bronchospasm can be provoked by cold inspired gases, tracheal intubation, tracheal extubation, and airway suctioning. Increased airway tone because of vagal stimulation can be caused by endoscopy or peritoneal or visceral stretching during surgery.^[@R37]^ Finally, asthmatic patients were more likely to have psychiatric illness, which is a contributing factor for postoperative adverse events.^[@R13],[@R38]^

This study has some limitations. First, Taiwan\'s National Health Insurance Research Database lacks data on asthmatic patients' current symptoms and lung function, as well as laboratory data that would facilitate analysis of the association between severity of asthma and postoperative adverse outcomes. Second, detailed information on sociodemographics, dietary habits, and lifestyle factors was not available in the insurance claims data for this study to validate the association of these factors with postoperative adverse outcomes. Third, although the surgical patients without asthma were those who had no medical visits for asthma within 24 months before the index surgery, some mild or borderline asthma may have existed in this group such that the influence of asthma on postoperative outcomes may be underestimated. Finally, although we used matching procedure and multivariate adjustment to control several confounders, residual confounding is possible.

In conclusion, we showed that asthma significantly increased postoperative pneumonia, sepsis, urinary tract infection and subsequent mortality, particularly for asthmatic patients with preoperative asthma-related emergency care, hospitalizations, ICU admissions, and use of systemic corticosteroids. These risk factors need to be routinely considered during preoperative assessment of surgical patients with asthma to provide better perioperative care for this population.

Abbreviations: CI = confidence interval, ICD-9-CM = International Classification of Diseases, 9th Revision, Clinical Modification, OR = odds ratio.
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